Clinical Trials Logo

Addiction, Alcohol clinical trials

View clinical trials related to Addiction, Alcohol.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06114316 Completed - Addiction, Alcohol Clinical Trials

Recovery of Individuals With Alcohol Use Disorders Based on Roy Adaptation Model

Start date: June 10, 2018
Phase: N/A
Study type: Interventional

Abstract Aim: This study aimed to determine the effect of individualized nursing interventions based on the Roy Adaptation Model on the recovery of alcohol addicts. Method: This was an experimental study with pretest-posttest, follow-up, and a control group. It included 64 individuals who completed their detoxification process and met the inclusion criteria. The experimental group was provided with individualized care, and interventions were made in line with the Roy Adaptation Model. The personal behaviors that could be related to recurrence (physiological, self-concept, role function, and mutual commitment) and the stimuli that caused recurrence (focal and affecting) were assessed, objectives were determined, and nursing interventions were carried out in line with these objectives. The interventions planned for diagnosing ineffective coping were selected according to the patients' needs among the "support coping" interventions under the title of the behavioral area in the Nursing Intervention Classification (NIC). The data were collected using an introductory information form, the Recovery Assessment Scale (RAS), the Turkish Version of the World Health Organization Quality of Life Instrument (WHOQOL-BREF-TR), and the Penn Alcohol Craving Scale (PACS).

NCT ID: NCT03232112 Completed - Addiction, Alcohol Clinical Trials

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

EXALT
Start date: August 7, 2017
Phase: Phase 2
Study type: Interventional

The study is a double-blinded, randomized, placebo-controlled, 26-weeks clinical trial. The objective of the trial is to investigate the effects of the GLP-1 receptor agonist Bydureon® (exenatide) vs. placebo on alcohol intake in patients with a diagnosis of alcohol dependence.